Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with silverberg scoring system for endocervical glandular lesions

International Journal of Gynecological Pathology

Volumn 26, Issue 1, 2007, Pages 71-75

  Liang, John ^a   Mittal, Khushbakhat Rai ^a   Wei, Jian Jun ^a   Yee, Herman ^a   Chiriboga, Lois ^a   Shukla, Pratibha ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

CEA; Gladular lesions; Ki67; p16; Uterine cervix

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P16INK4A; PROTEIN P53;

ARTICLE; BENIGN UTERUS TUMOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; EARLY DIAGNOSIS; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PATHOLOGIST; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SILVERBERG SCORING SYSTEM; TISSUE FIXATION; TISSUE SECTION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; UTERINE ENDOCERVIX;

CARCINOEMBRYONIC ANTIGEN; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KI-67 ANTIGEN; PRECANCEROUS CONDITIONS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 33845920618     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000225851.97739.9f     Document Type: Article

References (20)

1. Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 1991;77:912-7.
2. Cina SJ, Richardson MS, Austin RM, et al. Immunohistochemical staining for Ki67, carcinoembryonic antigen and p53 in the differential diagnosis of glandular lesions ofthe cervix. Mod Pathol 1997;10:176-80.
3. Pirog EC, Isacson C, Szabolcs MJ, et al. Proliferative activity of benign and neoplastic endocervical epithelium and correlation with HPV DNA detection. Int J Gynecol Pathol 2002;21:22-6.
4. Zaino RJ. Symposium part I: adenocarcinoma in situ, glandular dysplasia, and early invasive adenocarcinoma ofthe uterine cervix. Int J Gynecol Pathol 2002;21:314-26.
5. Zaino RJ. Glandular lesions ofthe uterine cervix. Mod Pathol 2000;13:261-74.
6. Ioffe OB, Sagae S, Moritani S, et al. Symposium part 3: should pathologists diagnose endocervical preneoplastic lesions "less than" adenocarcinoma in situ? J Gynecol Pathol 2003;22:18-21.
7. Marjoniemi VM. Immunohistochemistry in gynecological pathology: a review. Pathology 2004;36:109-19.
8. Negri G, Egarter-Vigl E, Kasal A, et al. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 2003;27:187-93.
9. Murphy N, Ring M, Killalea AG, et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 2003;56:56-63.
10. Riethdorf L, Riethdorf S, Lee KR, et al. Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. Human Pathol 2002;33:899-904.
11. Nieh S, Chen SF, Chu TY, et al. Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix. Gynecol Oncol 2003;91:201-8.
12. Alkushi A, Irving J, Hsu F, et al. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. Virchows Arch 2003;442:271-7.
13. Cina SJ, Richardson MS, Austin RM, et al. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol 1997;10:176-80.
14. Cameron RI, Maxwell P, Jenkins D, et al. Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology 2002;41:313-21.
15. Ismail SM. Cone biopsy causes cervical endometriosis and tuboendometrial, metaplasia. Histopathology 1991;18:107-14.
16. Al Nafussi A, Rahilly M. The prevalence of tubo-endometrial metaplasia and adenomatoid proliferation. Histopathology 1993;22:177-9.
17. Walboomers JMM, Jacobs MV, Manos MM. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
18. Chichareon S, Herrero R, Munoz N, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998;90:43-9.
19. Chaouki N, Bosch FX, Munoz N, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998;75:546-55.
20. KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas. Virchows Arch 2001;439:55-61.